Erratum: Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806))

Y. H. Ling; R. Lin; R. Perez-Soler

doi:10.1124/mol.107.044396

Erratum: Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptor^L858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806))

Y. H. Ling, R. Lin, R. Perez-Soler

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	391
Number of pages	1
Journal	Molecular Pharmacology
Volume	88
Issue number	2
DOIs	https://doi.org/10.1124/mol.107.044396
State	Published - Aug 1 2015
Externally published	Yes

ASJC Scopus subject areas

Molecular Medicine
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1124/mol.107.044396

Cite this

Ling, Y. H., Lin, R., & Perez-Soler, R. (2015). Erratum: Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptor^L858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806)). Molecular Pharmacology, 88(2), 391. https://doi.org/10.1124/mol.107.044396

Erratum: Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptor^L858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806)). / Ling, Y. H.; Lin, R.; Perez-Soler, R.
In: Molecular Pharmacology, Vol. 88, No. 2, 01.08.2015, p. 391.

Research output: Contribution to journal › Article › peer-review

Ling, YH, Lin, R & Perez-Soler, R 2015, 'Erratum: Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptor^L858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806))', Molecular Pharmacology, vol. 88, no. 2, pp. 391. https://doi.org/10.1124/mol.107.044396

Ling YH, Lin R, Perez-Soler R. Erratum: Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptor^L858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806)). Molecular Pharmacology. 2015 Aug 1;88(2):391. doi: 10.1124/mol.107.044396

Ling, Y. H. ; Lin, R. ; Perez-Soler, R. / Erratum : Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptor^L858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806)). In: Molecular Pharmacology. 2015 ; Vol. 88, No. 2. pp. 391.

@article{d360a90f70e9499c9ddb83915fc5e3ea,

title = "Erratum: Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806))",

author = "Ling, {Y. H.} and R. Lin and R. Perez-Soler",

year = "2015",

month = aug,

day = "1",

doi = "10.1124/mol.107.044396",

language = "English (US)",

volume = "88",

pages = "391",

journal = "Molecular Pharmacology",

issn = "0026-895X",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "2",

}

TY - JOUR

T1 - Erratum

T2 - Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK (Mol Pharmacol 74 (793-806))

AU - Ling, Y. H.

AU - Lin, R.

AU - Perez-Soler, R.

PY - 2015/8/1

Y1 - 2015/8/1

UR - http://www.scopus.com/inward/record.url?scp=84939781182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939781182&partnerID=8YFLogxK

U2 - 10.1124/mol.107.044396

DO - 10.1124/mol.107.044396

M3 - Article

C2 - 26130290

AN - SCOPUS:84939781182

SN - 0026-895X

VL - 88

SP - 391

JO - Molecular Pharmacology

JF - Molecular Pharmacology

IS - 2

ER -